Vanda Settles Sleep Drug Patent Claims Against MSN Pharma
Vanda Pharmaceuticals Inc. announced the settlement Friday of a multiyear patent dispute with MSN Pharmaceuticals and Impax Laboratories, based in part on a future licensing agreement with MSN and Impax covering...To view the full article, register now.
Already a subscriber? Click here to view full article